124 related articles for article (PubMed ID: 16570784)
1. [Misleading advice on cholesterol reduction].
Ravnskov U
Lakartidningen; 2006 Feb 22-28; 103(8):568; discussion 569. PubMed ID: 16570784
[No Abstract] [Full Text] [Related]
2. [Should cholesterol levels be reduced more aggressively?].
Ravnskov U
Lakartidningen; 2005 Sep 12-18; 102(37):2583-4; discussion 2584. PubMed ID: 16200908
[No Abstract] [Full Text] [Related]
3. [The lower LDL cholesterol the better!].
Stenestrand U; Olsson AG
Lakartidningen; 2004 Oct; 101(42):3246-7. PubMed ID: 15544130
[No Abstract] [Full Text] [Related]
4. [The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk].
Olsson AG
Lakartidningen; 2005 May 2-15; 102(18-19):1393-4. PubMed ID: 15929421
[No Abstract] [Full Text] [Related]
5. [Lower and lower cholesterol targets increase adverse effects].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B; ;
Lakartidningen; 2009 Sep 30-Oct 6; 106(40):2550-1. PubMed ID: 19908628
[No Abstract] [Full Text] [Related]
6. [LDL lowering--level and time. Maybe two equally important parameters for protection against arteriosclerosis].
Herlitz J
Lakartidningen; 2006 Oct 25-31; 103(43):3272-3. PubMed ID: 17117658
[No Abstract] [Full Text] [Related]
7. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
Carlson LA
Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
[No Abstract] [Full Text] [Related]
8. [Lowering cholesterol: how low is low enough?].
Czuriga I; Edes I
Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
[TBL] [Abstract][Full Text] [Related]
9. [Better with lower LDL cholesterol! Aim at 2 mmol/l for secondary prevention].
Olsson AG
Lakartidningen; 2006 Jan 11-17; 103(1-2):22-3. PubMed ID: 16465841
[No Abstract] [Full Text] [Related]
10. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
Rudling M
Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
[No Abstract] [Full Text] [Related]
11. Advances in the management of hyperlipidemia-induced atherosclerosis.
Tannock LR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
[TBL] [Abstract][Full Text] [Related]
12. Enhanced LDL-C reduction: lower is better. Does it matter how?
Viljoen A; Wierzbicki AS
Int J Clin Pract; 2008 Apr; 62(4):518-20. PubMed ID: 18324945
[No Abstract] [Full Text] [Related]
13. Should women with normal cholesterol be taking a statin? A major study suggests that statins also quell inflammation. Now what?
Harv Womens Health Watch; 2009 Feb; 16(6):1-3. PubMed ID: 19297742
[No Abstract] [Full Text] [Related]
14. [Plant stanoles in the prevention of cardiovascular diseases. Requirements regarding hard terminal points of soft margarines].
Astrup AV; Ovesen LF; Stender S
Ugeskr Laeger; 2001 Nov; 163(46):6437-9. PubMed ID: 11816923
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
16. A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study.
Farsang C; Athyros V; Gaw A;
Curr Med Res Opin; 2007 Aug; 23(8):1945-56. PubMed ID: 17626713
[TBL] [Abstract][Full Text] [Related]
17. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
[No Abstract] [Full Text] [Related]
18. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
Barter PJ; Rye KA
Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
[No Abstract] [Full Text] [Related]
19. Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.
Kastelein JJ; Wedel MK; Baker BF; Su J; Bradley JD; Yu RZ; Chuang E; Graham MJ; Crooke RM
Circulation; 2006 Oct; 114(16):1729-35. PubMed ID: 17030687
[TBL] [Abstract][Full Text] [Related]
20. Lipids and cardiovascular risk reduction -- new targets, new challenges.
Jackson G
Int J Clin Pract; 2005 Jun; 59(6):617-8. PubMed ID: 15924585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
